From prescriptions to drug use periods - Things to notice

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Tanskanen, Antti ^a,b,c   Taipale, Heidi ^c   Koponen, Marjaana ^c   Tolppanen, Anna Maija ^c   Hartikainen, Sirpa ^c   Ahonen, Riitta ^c   Tiihonen, Jari ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Drug utilization; Modeling; Pharmacoepidemiology; Prescription register

Indexed keywords

CITALOPRAM; DIURETIC AGENT; DRUG; LOSARTAN; METOPROLOL; TABLET; TEMAZEPAM;

ALZHEIMER DISEASE; DOSE RESPONSE; DRUG LABELING; HUMAN; PRESCRIPTION; TABLET; TIME;

ALZHEIMER DISEASE; CITALOPRAM; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG LABELING; DRUG PRESCRIPTIONS; HUMANS; LOSARTAN; METOPROLOL; PHARMACEUTICAL PREPARATIONS; TABLETS; TEMAZEPAM; TIME FACTORS;

EID: 84920855656     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-796     Document Type: Article

References (20)

1. Martikainen J, Klaukka T, Reunanen A, Peura S, Wahlroos H: Recent trends in the consumption of lipid-lowering drugs in Finland. J Clin Epidemiol 1996, 49:1453-1457.
2. Andersen UA, Andersen M, Rosholm JU, Gram LF: Contacts to the health care system prior to suicide: a comprehensive analysis using registers for general and psychiatric hospital admissions, contacts to general practitioners and practising specialists and drug prescriptions. Acta Psychiatr Scand 2000, 102:126-134.
3. Ehrenstein V, Antonsen S, Pedersen L: Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010, 2:273-279.
4. Helin-Salmivaara A, Klaukka T, Huupponen R: Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland. Eur J Clin Pharmacol 2003, 59:477-482.
5. Rasmussen F, Smedby B: Physician visits and prescribed drugs among young children and their mothers. Scand J Prim Health Care 1987, 5:225-231.
6. Ekedahl A, Lidbeck J, Lithman T, Noreen D, Melander A: Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community. Eur J Clin Pharmacol 1993, 44:141-146.
7. Wettermark B, Zoëga H, Furu K, Korhonen M, Hallas J, Nørgaard M, Almarsdottir AB, Andersen M, Anderson Sundell K, Bergman U, Helin-Salmivaara A, Hoffmann M, Kieler H, Martikainen JE, Mortensen M, Petzold M, Wallach-Kildermoes H, Wallin C, Sørensen HT: The Nordic prescription databases as a resource for pharmacoepidemiological research - a literature review. Pharmacoepidemiol Drug Saf 2013, 22:691-699.
8. Steiner JF, Koepsell TD, Fihn SD, Inui TS: A general method of compliance assessment using centralized pharmacy records. Med Care 1988, 26:814-823.
9. Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: methods, validity and applications. J Clin Epidemiol 1997, 50:105-116.
10. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT: The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010, 106:86-94.
11. WHO: DDD, Definition and General Considerations. 2013. http://www.whocc.no/ddd/definition-and-general-considera/Accessed November 1st.
12. Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S: Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study. Clin Epidemiol 2013, 5:277-284.
13. Bakken MS, Engeland A, Engesæter LB, Ranhoff AH, Hunskaar S, Ruths S: Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol 2014, 70:1972-1979.
14. Kemp A, Preen DB, Saunders C, Boyle F, Bulsara M, Malacova E, Roughead EE: Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice? Springerplus 2014, 3:282. doi:10.1186/2193-1801-3-282.
15. Bølling R, Scheller NM, Køber L, Poulsen HE, Gislason GH, Torp-Pedersen C: Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study. Eur J Heart Fail 2014, 16:678-684.
16. Andrade SE, Kahler KH, Frech F, Chan KA: Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006, 15:565-574.
17. Ringbäck Weitoft G, Berglund M, Lindström EA, Nilsson M, Salmi P, Rosén M: Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden - a register-based study. Pharmacoepidemiol Drug Saf 2014, 23:290-298.
18. Nielsen LH, Løkkegaard E, Andreasen AH, Keiding N: Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Pharmacoepidemiol Drug Saf 2008, 17:384-388.
19. Pharmaceutical Information Center: General information of Nordic Article number. 2013. wiki.vnr.fi.. Accessed November 1st.
20. Douglas IJ, Smeeth L: Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ 2008, doi:10.1136/bmj.a1227.